The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2016

Filed:

May. 17, 2013
Applicant:

Kuraray Noritake Dental Inc., Kurashiki-shi, JP;

Inventors:

Tadashi Hashimoto, Kurashiki, JP;

Mariko Sugiura, Kurashiki, JP;

Shumei Ishihara, Kurashiki, JP;

Mitsunobu Kawashima, Kurashiki, JP;

Koichi Okada, Tokyo, JP;

Assignee:

KURARAY NORITAKE DENTAL INC., Kurashiki-shi, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/02 (2006.01); A61Q 11/00 (2006.01); A61K 47/04 (2006.01); A61P 1/02 (2006.01); A61K 6/033 (2006.01); A61P 25/02 (2006.01); A61K 33/16 (2006.01); A61K 8/24 (2006.01); A61K 33/42 (2006.01); A61K 6/00 (2006.01); A61K 8/02 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 33/42 (2013.01); A61K 6/0017 (2013.01); A61K 6/033 (2013.01); A61K 8/0241 (2013.01); A61K 8/24 (2013.01); A61K 33/16 (2013.01); A61K 45/06 (2013.01); A61Q 11/00 (2013.01); A61K 2800/412 (2013.01);
Abstract

A method for inhibiting dentinal hypersensitivity by applying a dentinal hypersensitivity inhibitor on a dentin surface. The dentinal hypersensitivity inhibitor contains at least one tetracalcium phosphate particle, an alkali metal salt of phosphoric acid, and at least one acidic calcium phosphate particle. The tetracalcium phosphate particle has an average particle diameter of 0.5 to 40 μm. The dentinal hypersensitivity inhibitor contains a blended amount of the tetracalcium phosphate particle of 5 to 55 parts by weight relative to 100 parts by weight of a whole amount of the dentinal hypersensitivity inhibitor and a blended amount of the alkali metal salt of phosphoric acid of 1 to 100 parts by weight relative to 100 parts by weight of the tetracalcium phosphate particle.


Find Patent Forward Citations

Loading…